A Phase I/II Study of S-1 and Oxaliplatin Combined With Radiation for Preoperative Locally Advanced Rectal Carcinoma.

Trial Profile

A Phase I/II Study of S-1 and Oxaliplatin Combined With Radiation for Preoperative Locally Advanced Rectal Carcinoma.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 11 Oct 2016

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin
  • Indications Rectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SHOGUN
  • Most Recent Events

    • 11 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 11 Oct 2016 Final results of SHOGUN trial assessing safety and efficacy of S-1 plus oxaliplatin combined with radiation, presented at the 41st European Society for Medical Oncology Congress
    • 26 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top